Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F. Holtz, W.R. Hart.
Krukenberg tumor: a clinico-pathologic analysis of 27 cases.
Cancer, 50 (1982), pp. 2438-2447
[2.]
J.S. Berek, G.M. Thomas, R.F. Ozols.
Ovarian cancer.
Cancer medicine (4.a ed.), pp. 2289-2326
[3.]
R. Bernabe, J. Reina, J. Salvador, M. Chaves, A. Rodríguez, M. Noguer, et al.
Epirrubicin, cisplatin and UFT (ECU): a less toxic regimen in the treatment of advanced gastric cancer.
Proc Am Soc Clin Oncol, 19 (2000), pp. 1207
[4.]
A. Viste, A.B. Rygh, O. Soreide.
Cancer of the stomach, is a follow-up programme of any importance for the patient?.
Clin Oncol, 10 (1984), pp. 325-332
[5.]
E. Hornstein, Y. Skornick, R. Rozin.
Radical surgical treatment for Krukenberg tumour.
Clin Oncol, 8 (1982), pp. 279-282
[6.]
F.M. McGill, D.B. Ritter, C.S. Rickard, R.N. Kaleya, S. Wadler, W.M. Greston, et al.
Krukenberg tumors: can management be improved?.
Gynecol Obstet Invest, 48 (1999), pp. 61-65
[7.]
J. Hermans, J.J. Bonenkamp, M.C. Boon, A.M. Bunt, S. Ohyama, M. Sasako, et al.
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomised trial.
J Clin Oncol,, 11 (1993), pp. 1441-1447
[8.]
C.C. Earle, J.A. Maroun.
Adjuvant chemotherapy after curative resection for gastric cancer: revisting a meta-analysis of randomised trials.
Proc Am Soc Clin Oncol, 17 (1998), pp. A263
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
